| Identification | Back Directory | [Name]
1H-INDOLE-3-CARBALDEHYDE N-(8-QUINOLINYL)HYDRAZONE | [CAS]
418800-15-4 | [Synonyms]
LDK
Lenaldekar
1H-INDOLE-3-CARBALDEHYDE N-(8-QUINOLINYL)HYDRAZONE
8-[(E)-2-[(1H-indol-3-yl)methylidene]hydrazin-1-yl]quinoline | [Molecular Formula]
C18H14N4 | [MDL Number]
MFCD00409836 | [MOL File]
418800-15-4.mol | [Molecular Weight]
286.33 |
| Chemical Properties | Back Directory | [Boiling point ]
549.8±38.0 °C(Predicted) | [density ]
1.26±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO: 100mg/mL | [form ]
powder | [pka]
11.02±0.70(Predicted) | [color ]
yellow |
| Hazard Information | Back Directory | [Description]
Lenaldekar is a inhibitor of T-cell expansion and autoimmune encephalomyelitis. | [Uses]
Lenaldekar (LDK) inhibits human and murine T-cell expansiomn. Lenaldekar inhibits autoimmune T cell response. Lenaldekar also induces cancer cell apoptosis. Lenaldekar can be used for T-cell mediated autoimmune diseases research[1][2]. | [in vivo]
Lenaldekar (40 mg/kg per day, i.p.) inhibits experimental autoimmune encephalomyelitis (EAE) relapse in mice sensitized with the encephalitogenic PLP139-151 peptide[1].
Lenaldekar (16 mg/kg, i.p., twice daily) inhibits tumor progession in a mouse xenograft model of T-cell acute lymphoblastic leukemia (T-ALL)[2].
| [References]
[1] Cusick MF, et al. Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen. J Neuroimmunol. 2012 Mar;244(1-2):35-44. DOI:10.1016/j.jneuroim.2011.12.024
[2] Ridges S, et al, et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood. 2012 Jun 14;119(24):5621-31. DOI:10.1182/blood-2011-12-398818 |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
| Company Name: |
Key Organics Ltd.
|
| Tel: |
+44 (0) 1840-212137 |
| Website: |
www.keyorganics.net |
|